Home / People / Carl Leermakers
Portrait of Carl Leermakers

Carl Leermakers


CMS DeBacker
Chaussée de La Hulpe 178
1170 Brussels
Languages Dutch, French, English

Carl Leermakers specializes in mergers and acquisitions and corporate transactional work. With more than twenty years of experience in these areas within CMS Belgium, his expertise ranges from advising on international corporate structures, over assisting clients in negotiating acquisitions, public offerings and take-over bids, to setting up leveraged buy-outs and exit strategies, tailoring W&I insurances and assessing and negotiating compliance with regulatory requirements. He also conducts litigation related to acquisitions, mostly claims on representations and warranties, including W&I insurance claims.

more less

Relevant experience

  • Advising the purchaser in a public takeover bid of a large Belgian banking and insurance company
  • IPO, Europe-wide, of financial instruments representing investments in ‘green energy’
  • Restructuring and refinancing (through tolling and securitisation) for the Belgian operations of an international group, (Legal 500 – 2008)
  • Advising international insurers on representations and warranties insurances linked to acquisitions in Belgium
  • Claims management for international insurers on around 60% of all claims involving, since 2007, more than 100 million EUR exposure for insurers in Belgium
  • Cross-border mergers of Belgian and EU banks and insurance companies
more less

Memberships & Roles

  • Head of the firm’s Insurance practice
more less


  • 1989 - Katholieke Universiteit Leuven, KUL (Law Degree)
  • 1990 - Katholieke Universiteit Leuven, KUL (Postgraduate degree in Notarial Law)
  • 1990 - Bar admission (Brussels, Belgium)
more less
Sep 2018
CMS European M&A Out­look
Wel­come to the sixth edi­tion of the CMS European M&A Out­look, pub­lished in as­so­ci­ation with Mer­ger­mar­ket. The op­tim­ism amongst deal­makers we re­por­ted in au­tumn last year was well-foun­ded: the mar­ket...
22 March 2017
CMS European M&A Study 2017
In geo­pol­it­ic­al terms, there has been noth­ing to com­pare with 2016 since the end of the Cold War. Neither Brexit nor the elec­tion of Pres­id­ent Trump was ex­pec­ted. The po­ten­tial im­pact of either event...


Show only
CMS European M&A Study 2021: Europe pivots to be­come more ‘buy­er-friendly’...
Europe has re­turned to a ‘buy­er-friendly’ en­vir­on­ment, sim­il­ar to the US where more ‘buy­er-friendly’ po­s­i­tions are com­mon, after the COV­ID-19 pan­dem­ic cre­ated more risk-averse at­ti­tudes. As a...
CMS Bel­gi­um as­sisted Prox­imus in es­tab­lish­ing a part­ner­ship with EQT In­fra­struc­ture...
CMS Bel­gi­um as­sisted Tele­com op­er­at­or Prox­imus in con­nec­tion with the es­tab­lish­ment of a part­ner­ship with EQT In­fra­struc­ture (through its port­fo­lio com­pany DELTA Fiber) for build­ing a fibre net­work to­geth­er...
Who dares wins: European M&A Out­look 2020
The COV­ID-19 pan­dem­ic has taken a heavy toll on European deal­mak­ing activ­ity. However, op­por­tun­it­ies re­main for those will­ing to take risks, ac­cord­ing to the eighth edi­tion of the European M&A Out­look...
10 April 2020
Im­pact of the Coronavir­us on the or­gan­iz­a­tion of an­nu­al gen­er­al meet­ings...
Bel­gian au­thor­it­ies, like some of their European coun­ter­parts, have taken ex­treme meas­ures to fight the spread of Cov­id-19, in­clud­ing re­stric­tions on so­cial gath­er­ings. If these strong meas­ures con­tin­ue...
CMS re­cog­nised for out­stand­ing M&A ad­vis­ory work
CMS has been re­cog­nised by Mer­ger­mar­ket for its out­stand­ing M&A ad­vis­ory work for deals in the value range of EUR 30m-EUR 1bn. Oth­er nom­in­ees in this cat­egory – “European Mid-Mar­ket M&A Leg­al Ad­viser...
European M&A ex­ec­ut­ives cau­tious over deal­mak­ing pro­spects
Brus­sels, 5 Septem­ber 2019. Weak eco­nom­ic in­dic­at­ors, un­cer­tainty sur­round­ing Brexit and grow­ing pro­tec­tion­ism in glob­al trade have con­trib­uted to a shift in sen­ti­ment in the M&A com­munity and the be­gin­ning...
June 2019
CMS Private Equity Glob­al Bro­chure
Private equity in­vestors face daily pres­sures of ori­gin­a­tion, valu­ations, ex­e­cu­tion, per­form­ance, exit strategies, fund rais­ing and reg­u­la­tion. At CMS, our private equity strategy is de­signed around our...
CMS Bel­gi­um as­sisted Guard­Square and its share­hold­ers with an in­vest­ment...
CMS Bel­gi­um as­sisted Guard­Square, a fast-grow­ing and mar­ket-lead­ing Bel­gian tech­start-up that provides mo­bile ap­plic­a­tion pro­tec­tion soft­ware, and its share­hold­ers with an im­port­ant in­vest­ment by Bat­tery...
CMS Bel­gi­um as­sisted Or­aS­ure Tech­no­lo­gies in the ac­quis­i­tion of Nov­osanis...
CMS Bel­gi­um as­sisted Or­aS­ure Tech­no­lo­gies, a US com­pany lis­ted on NAS­DAQ and a lead­er in the med­ic­al device in­dustry, in con­nec­tion with its ac­quis­i­tion of Nov­osanis NV, a Bel­gian com­pany act­ive in the...
31 January 2018
Ten things every in­surer should know
Alex Denslow, CMS Lon­don: “De­lighted to launch the 3rd ed. of “10 Things Every In­surer Should Know”, in which we com­pare 10 key in­sur­ance is­sues across 29 jur­is­dic­tions where the CMS In­sur­ance Sec­tor...
28 September 2017
So­ciaalrechtelijke as­pec­ten in een M&A deal
Hoewel M&A pro­jec­ten ge­woon­lijk worden aanges­tuurd door cor­por­ate of tax ad­voc­aten, hebben in veel geval­len ook de so­ciaalrechtelijke as­pec­ten een aan­zi­en­lijke in­vloed op het al dan niet suc­ces­vol sluiten...
22 May 2017
Cross bor­der In­sur­ance sem­in­ar
We are de­lighted to in­vite you to our Cross-bor­der In­sur­ance sem­in­ar at the WTC in Rot­ter­dam on 22 May 2017.The sem­in­ar will be hos­ted by law­yers from our CMS in­sur­ance sec­tor group in the Neth­er­lands...